SE0102320D0 - Novel treatment of adrenocortical hypersecretion and tumour growth - Google Patents

Novel treatment of adrenocortical hypersecretion and tumour growth

Info

Publication number
SE0102320D0
SE0102320D0 SE0102320A SE0102320A SE0102320D0 SE 0102320 D0 SE0102320 D0 SE 0102320D0 SE 0102320 A SE0102320 A SE 0102320A SE 0102320 A SE0102320 A SE 0102320A SE 0102320 D0 SE0102320 D0 SE 0102320D0
Authority
SE
Sweden
Prior art keywords
sub
hypersecretion
adrenocortical
halogen
tumor growth
Prior art date
Application number
SE0102320A
Other languages
English (en)
Inventor
Ingvar Brandt
Original Assignee
Ingvar Brandt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ingvar Brandt filed Critical Ingvar Brandt
Priority to SE0102320A priority Critical patent/SE0102320D0/sv
Publication of SE0102320D0 publication Critical patent/SE0102320D0/sv
Priority to US10/482,203 priority patent/US7091248B2/en
Priority to EP02744060A priority patent/EP1412311A1/en
Priority to PCT/SE2002/001293 priority patent/WO2003002495A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
    • C07C25/24—Halogenated aromatic hydrocarbons with unsaturated side chains
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0102320A 2001-06-27 2001-06-27 Novel treatment of adrenocortical hypersecretion and tumour growth SE0102320D0 (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE0102320A SE0102320D0 (sv) 2001-06-27 2001-06-27 Novel treatment of adrenocortical hypersecretion and tumour growth
US10/482,203 US7091248B2 (en) 2001-06-27 2002-06-27 Treatment of adrenocortical hypersecretion and tumor growth
EP02744060A EP1412311A1 (en) 2001-06-27 2002-06-27 Novel treatment of adrenocortical hypersecretion and tumour growth
PCT/SE2002/001293 WO2003002495A1 (en) 2001-06-27 2002-06-27 Novel treatment of adrenocortical hypersecretion and tumour growth

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102320A SE0102320D0 (sv) 2001-06-27 2001-06-27 Novel treatment of adrenocortical hypersecretion and tumour growth

Publications (1)

Publication Number Publication Date
SE0102320D0 true SE0102320D0 (sv) 2001-06-27

Family

ID=20284669

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102320A SE0102320D0 (sv) 2001-06-27 2001-06-27 Novel treatment of adrenocortical hypersecretion and tumour growth

Country Status (4)

Country Link
US (1) US7091248B2 (sv)
EP (1) EP1412311A1 (sv)
SE (1) SE0102320D0 (sv)
WO (1) WO2003002495A1 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7470723B2 (en) * 2003-03-05 2008-12-30 Celgene Corporation Diphenylethylene compounds and uses thereof

Also Published As

Publication number Publication date
US7091248B2 (en) 2006-08-15
US20040242705A1 (en) 2004-12-02
WO2003002495A1 (en) 2003-01-09
EP1412311A1 (en) 2004-04-28

Similar Documents

Publication Publication Date Title
MY135477A (en) 2-(2,6-dichlorophenyl)-diarylimidazoles
DE60112974D1 (en) Carbolinderivate
BRPI0411365A (pt) derivados de aminopiridina
UA83243C2 (ru) Соединения, которые ингибируют натриезависимый переносчик глюкозы
TNSN04065A1 (en) Treatment of acute myeloid leukemia with indolinone compounds
ATE398125T1 (de) Chinazolin-derivate als tgf-beta-inhibitoren
GB0318343D0 (en) No title
RS52625B (en) FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR TREATMENT AND PREVENTION OF DISEASES AND DISEASES
DE60030741D1 (de) Chinazoline verbindungen als heilmittel
ATE346067T1 (de) Carbolinderivate
DE60334536D1 (de) Furylverbindungen
SE0002320D0 (sv) Malignant tumors
MXPA02012076A (es) Compuestos quimicos.
AU2001266575A1 (en) Chemical compounds
NZ509244A (en) Treatment regimen for administration of phenylacetylglutamine phenylacetylisoglutamine, and/or phenylacetate
IS5588A (is) Æxliseyðandi miðlar
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
SE0203303D0 (sv) Novel Compounds
ATE390923T1 (de) Topoisomerase-giftmittel
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
SE0102320D0 (sv) Novel treatment of adrenocortical hypersecretion and tumour growth
MXPA02012472A (es) Compuestos quimicos.
MXPA05006957A (es) Nuevos derivados de fosforamida.
TW200500068A (en) Crystalline therapeutic agent
SE0004827D0 (sv) Therapeutic compounds